Christian G Rabbat

Summary

Affiliation: McMaster University
Country: Canada

Publications

  1. ncbi Prognostic value of myocardial perfusion studies in patients with end-stage renal disease assessed for kidney or kidney-pancreas transplantation: a meta-analysis
    Christian G Rabbat
    Department of Medicine, Division of Nephrology, McMaster University, Hamilton, Ontario, Canada
    J Am Soc Nephrol 14:431-9. 2003
  2. ncbi Red blood cell transfusion and increased length of storage are not associated with deep vein thrombosis in medical and surgical critically ill patients: a prospective observational cohort study
    Christina Katsios
    Department of Medicine, McMaster University, 1200 Main Street West, Hamilton, ON L8S 4L8, Canada
    Crit Care 15:R263. 2011
  3. ncbi Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factors
    Deborah Cook
    Department of Medicine, 1200 Main Street, McMaster University, Hamilton, Canada
    Crit Care 12:R32. 2008
  4. ncbi Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency
    Christian G Rabbat
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada L8N 3Z5
    J Crit Care 20:357-63. 2005
  5. ncbi Protocolized anemia management with erythropoietin in hemodialysis patients: a randomized controlled trial
    K Scott Brimble
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    J Am Soc Nephrol 14:2654-61. 2003
  6. ncbi Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors
    Mark A Crowther
    Department of Medicine and Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada L8N 3Z5
    J Crit Care 20:348-53. 2005
  7. ncbi Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis
    K Scott Brimble
    25 Charlton Avenue East, Hamilton, ON, Canada, L8N 1Y2
    J Am Soc Nephrol 17:2591-8. 2006
  8. ncbi Impact of haemoglobin and erythropoietin dose changes on mortality: a secondary analysis of results from a randomized anaemia management trial
    Joanne H Lau
    Division of Nephrology, Department of Medicine, McMaster University, Hamilton, Canada
    Nephrol Dial Transplant 25:4002-9. 2010
  9. ncbi Thromboembolism and anticoagulant management in hemodialysis patients: a practical guide to clinical management
    Dorothy S Lo
    Department of Medicine, McMaster University, 25 Charlton Avenue, Hamilton, Ontario, Canada
    Thromb Res 118:385-95. 2006

Collaborators

Detail Information

Publications9

  1. ncbi Prognostic value of myocardial perfusion studies in patients with end-stage renal disease assessed for kidney or kidney-pancreas transplantation: a meta-analysis
    Christian G Rabbat
    Department of Medicine, Division of Nephrology, McMaster University, Hamilton, Ontario, Canada
    J Am Soc Nephrol 14:431-9. 2003
    ..It is concluded that positive MPS are useful in identifying patients with significantly increased risk of future MI and CD in both diabetic and nondiabetic ESRD patients...
  2. ncbi Red blood cell transfusion and increased length of storage are not associated with deep vein thrombosis in medical and surgical critically ill patients: a prospective observational cohort study
    Christina Katsios
    Department of Medicine, McMaster University, 1200 Main Street West, Hamilton, ON L8S 4L8, Canada
    Crit Care 15:R263. 2011
    ..The objective of this study was to determine if RBC transfusions or RBC storage age predicts incident DVT in medical or surgical intensive care unit (ICU) patients...
  3. ncbi Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factors
    Deborah Cook
    Department of Medicine, 1200 Main Street, McMaster University, Hamilton, Canada
    Crit Care 12:R32. 2008
    ..The objective of the present study was to evaluate the prevalence, incidence and predictors of DVT and the incidence of bleeding in intensive care unit (ICU) patients with estimated creatinine clearance <30 ml/min...
  4. ncbi Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency
    Christian G Rabbat
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada L8N 3Z5
    J Crit Care 20:357-63. 2005
    ..If dalteparin does not bioaccumulate, it may be an attractive alternative agent for thromboprophylaxis...
  5. ncbi Protocolized anemia management with erythropoietin in hemodialysis patients: a randomized controlled trial
    K Scott Brimble
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    J Am Soc Nephrol 14:2654-61. 2003
    ..This study demonstrated that a protocolized approach to anemia management in hemodialysis patients results in comparable Hgb levels and may reduce rHuEpo requirements, independent of iron use...
  6. ncbi Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors
    Mark A Crowther
    Department of Medicine and Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada L8N 3Z5
    J Crit Care 20:348-53. 2005
    ..Heparin-induced thrombocytopenia was frequently suspected but did not develop in these critically ill patients...
  7. ncbi Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis
    K Scott Brimble
    25 Charlton Avenue East, Hamilton, ON, Canada, L8N 1Y2
    J Am Soc Nephrol 17:2591-8. 2006
    ..96 to 1.46; P = 0.12) for every 0.1 increase in the D/Pc. This meta-analysis demonstrates that a higher peritoneal membrane solute transport rate is associated with a higher mortality risk and a trend to higher technique failure...
  8. ncbi Impact of haemoglobin and erythropoietin dose changes on mortality: a secondary analysis of results from a randomized anaemia management trial
    Joanne H Lau
    Division of Nephrology, Department of Medicine, McMaster University, Hamilton, Canada
    Nephrol Dial Transplant 25:4002-9. 2010
    ..To date, no study has evaluated the impact of Hgb variability on mortality in the setting of a uniform Hgb target and erythropoiesis-stimulating agents (ESA) dosing strategy...
  9. ncbi Thromboembolism and anticoagulant management in hemodialysis patients: a practical guide to clinical management
    Dorothy S Lo
    Department of Medicine, McMaster University, 25 Charlton Avenue, Hamilton, Ontario, Canada
    Thromb Res 118:385-95. 2006
    ....